Role and Mechanism of Gut Microbiota in Human Disease

Abbasalizad Farhangi, 2020, Gut microbiota-associated trimethylamine N-oxideand increased cardiometabolic risk in adults: a systematic review and dose-responsemeta-analysis, Nutr. Rev, 1, 10.1093/nutrit/nuaa111

Abbott, 2020, Are infections seeding some cases of Alzheimer’s disease, Nature, 587, 22, 10.1038/d41586-020-03084-9

Almeida, 2020, A unified catalog of 204,938 reference genomesfrom the human gut microbiome, Nat. Biotechnol., 39, 105, 10.1038/s41587-020-0603-3

Aoki, 2017, A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation, Sci. Rep., 7, 10.1038/srep43522

Bakay, 2019, The Genetic Contribution to Type 1 Diabetes, Curr. Diabetes Rep., 19, 116, 10.1007/s11892-019-1235-1

Bedarf, 2017, Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients, Genome Med., 9, 39, 10.1186/s13073-017-0428-y

Beyer, 2009, Molecular pathology of Lewy body diseases, Int. J. Mol. Sci., 10, 724, 10.3390/ijms10030724

Bharwani, 2017, Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress, BMC Med., 15, 7, 10.1186/s12916-016-0771-7

Brown, 2016, Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice, ISME J., 10, 321, 10.1038/ismej.2015.114

Canfora, 2019, Gut microbial metabolites in obesity, NAFLD and T2DM, Nat. Rev. Endocrinol., 15, 261, 10.1038/s41574-019-0156-z

Caruso, 2020, Host–microbiota interactions in inflammatory bowel disease, Nat. Rev. Immunol., 20, 411, 10.1038/s41577-019-0268-7

Chatterjee, 2017, Type 2 diabetes, Lancet, 389, 2239, 10.1016/s0140-6736(17)30058-2

Chen, 2020, Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer’s disease mouse model, Sci. Adv., 6, 10.1126/sciadv.aba0466

Chou, 2019, Trimethylamine N-Oxide, Circulating EndothelialProgenitor Cells, and Endothelial Function in Patients with Stable Angina, Sci. Rep., 9, 4249, 10.1038/s41598-019-40638-y

Chu, 2019, Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease, Gut, 68, 359, 10.1136/gutjnl-2018-316307

Collaboration, 2017, Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants, Lancet, 389, 37, 10.1016/S0140-6736(16)31919-5

Collins, 2012, The interplay between the intestinal microbiota and the brain, Nat. Rev. Microbiol., 10, 735, 10.1038/nrmicro2876

Crusell, 2018, Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum, Microbiome, 6, 89, 10.1186/s40168-018-0472-x

Da Silva, 2018, Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance, Sci. Rep., 8, 1466, 10.1038/s41598-018-19753-9

De La Cuesta-Zuluaga, 2018, Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization, Sci. Rep., 8, 11356, 10.1038/s41598-018-29687-x

De Munck, 2020, Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis, Liver Int., 40, 2906, 10.1111/liv.14696

De Palma, 2015, Microbiota and host determinants of behavioural phenotype in maternally separated mice, Nat. Commun., 6, 7735, 10.1038/ncomms8735

De Vadder, 2016, Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis, Cell Metab., 24, 151, 10.1016/j.cmet.2016.06.013

Del Bo, 2020, A polyphenol-rich dietary pattern improvesintestinal permeability, evaluated as serum zonulin levels, in older subjects: The MaPLE randomisedcontrolled trial, Clin. Nutr., S0261-5614(20)30689-0

Ding, 2019, Revisit gut microbiota and its impact on human health and disease, J. Food Drug Anal., 27, 623, 10.1016/j.jfda.2018.12.012

Donertas Ayaz, 2020, Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide, Pharmacol. Res., 153, 10.1016/j.phrs.2020.104677

Durgan, 2017, Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota, Curr. Hypertens. Rep., 19, 35, 10.1007/s11906-017-0732-3

Ebrahimzadeh Leylabadlo, 2020, From role of gut microbiota to microbial-based therapies in type 2-diabetes, Infect. Genet. Evol., 81, 10.1016/j.meegid.2020.104268

Eftychi, 2019, Temporally distinct functions of the cytokines IL-12 and IL-23 drive chronic colon inflammation in response to intestinal barrier impairment, Immunity, 51, 367, 10.1016/j.immuni.2019.06.008

Elfil, 2020, Implications of the Gut Microbiome in Parkinson’s Disease, Mov Disord., 35, 921, 10.1002/mds.28004

Fan, 2021, Gut microbiota in human metabolic health and disease, Nat. Rev. Microbiol., 19, 55, 10.1038/s41579-020-0433-9

Fluckiger, 2020, Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage, Science, 369, 936, 10.1126/science.aax0701

Garrett, 2019, The gut microbiota and colon cancer, Science, 364, 1133, 10.1126/science.aaw2367

Gerhardt, 2018, Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases, Nutrients, 10, 708, 10.3390/nu10060708

Haghikia, 2018, Gut microbiota-dependent TMAO and risk of cardiovascular events in patients with stroke: relation to pro-inflammatory monocytes, Eur. Heart J., 39, 475, 10.1093/eurheartj/ehy565.P2467

Harach, 2017, Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Sci. Rep., 7, 10.1038/srep41802

Hasain, 2020, Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential, Front. Cell Infect. Microbiol., 10, 10.3389/fcimb.2020.00188

Heintz-Buschart, 2018, The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder, Movement Disord., 33, 88, 10.1002/mds.27105

Hill-Burns, 2017, Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome, Mov Disord., 32, 739, 10.1002/mds.26942

Homayouni, 2020, Prevention of Gestational Diabetes Mellitus (GDM) and Probiotics: Mechanism of Action: A Review, Curr. Diabetes Rev., 16, 538, 10.2174/1573399815666190712193828

Hopfner, 2017, Gut microbiota in Parkinson disease in a northern German cohort, Brain Res., 1667, 41, 10.1016/j.brainres.2017.04.019

Hoyles, 2018, Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women, Nat. Med., 24, 1070, 10.1038/s41591-018-0061-3

Iruzubieta, 2020, A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression, J. Clin. Med., 9, 1369, 10.3390/jcm9051369

Jahansouz, 2016, Bile Acids Increase Independently From Hypocaloric Restriction After Bariatric Surgery, Ann. Surg., 264, 1022, 10.1097/sla.0000000000001552

Jensen, 2018, Increase in clinically recorded type 2 diabetesafter colectomy, Elife, 7, 10.7554/eLife.37420

Jiang, 2015, Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease, J. Clin. Invest., 125, 386, 10.1172/jci76738

Jie, 2017, The gut microbiome in atherosclerotic cardiovascular disease, Nat. Commun., 8, 845, 10.1038/s41467-017-00900-1

Jonsson, 2017, Role of gut microbiota in atherosclerosis, Nat. Rev. Cardiol., 14, 79, 10.1038/nrcardio.2016.183

Kadosh, 2020, The gut microbiome switches mutant p53 fromtumour-suppressive to oncogenic, Nature, 586, 133, 10.1038/s41586-020-2541-0

Karbach, 2016, Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction, J. Am. Heart Assoc., 5, 10.1161/JAHA.116.003698

Kelly, 2015, Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function, Cell Host Microbe, 17, 662, 10.1016/j.chom.2015.03.005

Kim, 2020, Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model, Gut, 69, 283, 10.1136/gutjnl-2018-317431

Kim, 2020, Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A, Nat. Commun., 11, 5969, 10.1038/s41467-020-19803-9

Kobayashi, 2017, Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease, Sci. Rep., 7, 13510, 10.1038/s41598-017-13368-2

Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat. Med., 19, 576, 10.1038/nm.3145

Kozarov, 2005, Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis, Arterioscler. Thromb. Vasc. Biol., 25, e17, 10.1161/01.ATV.0000155018.67835.1a

Kuang, 2017, Connections between the human gut microbiome and gestational diabetes mellitus, GigaScience, 6, 1, 10.1093/gigascience/gix058

Larraufie, 2018, SCFAs strongly stimulate PYY production in human enteroendocrine cells, Sci. Rep., 8, 74, 10.1038/s41598-017-18259-0

Lavelle, 2020, Gut microbiota-derived metabolites as key actorsin inflammatory bowel disease, Nat. Rev. Gastroenterol. Hepatol., 17, 223, 10.1038/s41575-019-0258-z

Li, 2019, Mild cognitive impairment has similar alterations as Alzheimer’s disease in gut microbiota, Alzheimers Dement., 15, 1357, 10.1016/j.jalz.2019.07.002

Li, 2019, Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China, Front. Mol. Neurosci., 12, 10.3389/fnmol.2019.00171

Li, 2014, Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease, J. Clin. Gastroenterol., 48, 513, 10.1097/mcg.0000000000000035

Li, 2016, Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice, Circulation, 133, 2434, 10.1161/circulationaha.115.019645

Li, 2020, Implication of the gut microbiome composition of type 2 diabetic patients from northern China, Sci. Rep., 10, 5450, 10.1038/s41598-020-62224-3

Li, 2017, Gut microbiota dysbiosis contributes to the development of hypertension, Microbiome, 5, 14, 10.1186/s40168-016-0222-x

Li, 2017, Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors, Eur. Heart J., 38, 814, 10.1093/eurheartj/ehw582

Lin, 2018, Gut microbiota in patients with Parkinson’s disease in southern China, Parkinsonism Relat. Disord., 53, 82, 10.1016/j.parkreldis.2018.05.007

Liu, 2017, Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention, Nat. Med., 23, 859, 10.1038/nm.4358

Long, 2019, Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity, Nat. Microbiol., 4, 1, 10.1038/s41564-019-0541-3

Macia, 2015, Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome, Nat. Commun., 6, 6734, 10.1038/ncomms7734

Mancuso, 2017, Alzheimer’s disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence, Pharmacol. Res., 129, 329, 10.1016/j.phrs.2017.12.009

Maria, 2010, The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment, J. Alzheimer’s Dis., 19, 909, 10.3233/JAD-2010-1285

Meng, 2015, Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases, Br. J. Pharmacol., 172, 5501, 10.1111/bph.12900

Miao, 2020, Erythrocyte n-6 Polyunsaturated Fatty Acids, Gut Microbiota and Incident Type 2 Diabetes: A Prospective Cohort Study, Curr. Develop. Nutr., 4, 1452, 10.1093/cdn/nzaa061_080

Minter, 2017, Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP(SWE)/PS1(ΔE9) murine model of Alzheimer’s disease, Sci. Rep., 7, 10411, 10.1038/s41598-017-11047-w

Mitra, 2015, In silico analyses of metagenomes from human atherosclerotic plaque samples, Microbiome, 3, 38, 10.1186/s40168-015-0100-y

Mollica, 2017, Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice, Diabetes, 66, 1405, 10.2337/db16-0924

Morais, 2020, The gut microbiota-brain axis in behaviour and brain disorders, Nat. Rev. Microbiol., 10.1038/s41579-020-00460-0

Muller, 2020, Microbiota-modulated CART(+) enteric neuronsautonomously regulate blood glucose, Science, 370, 314, 10.1126/science.abd6176

Murray, 2015, Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countrie, Lancet, 386, 2145, 10.1016/S0140-6736(15)61340-X

Nagpure, 2016, Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System, Oxid. Med. Cell. Longevity, 2016, 6904327, 10.1155/2016/6904327

Nemet, 2020, A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors, Cell, 180, e822, 10.1016/j.cell.2020.02.016

Nie, 2018, Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients, Stroke, 49, 2021, 10.1161/strokeaha.118.021997

Pan, 2018, miR-192 is upregulated in T1DM, regulates pancreatic β-cell development and inhibits insulin secretion through suppressing GLP-1 expression, Exp. Ther. Med., 16, 2717, 10.3892/etm.2018.6453

Peng, 2018, Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies, Nature, 557, 558, 10.1038/s41586-018-0104-4

Qian, 2018, Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease, Brain Behav. Immun., 70, 194, 10.1016/j.bbi.2018.02.016

Raman, 2013, Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease, Clin. Gastroenterol. Hepatol., 11, 868, 10.1016/j.cgh.2013.02.015

Robles-Vera, 2017, Antihypertensive Effects of Probiotics, Curr. Hypertens. Rep., 19, 26, 10.1007/s11906-017-0723-4

Rom, 2020, Glycine-based treatment ameliorates NAFLD bymodulating fatty acid oxidation, glutathione synthesis, and the gut microbiome, Sci. Transl. Med., 12, 10.1126/scitranslmed.aaz2841

Sampson, 2016, Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease, Cell, 167, 1469, 10.1016/j.cell.2016.11.018

Sanchez-Rodriguez, 2020, The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases, Nutrients, 12, 605, 10.3390/nu12030605

Schaubeck, 2016, Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defence, Gut, 65, 225, 10.1136/gutjnl-2015-309333

Scheperjans, 2015, Gut microbiota are related to Parkinson’s disease and clinical phenotype, Mov Disord., 30, 350, 10.1002/mds.26069

Shikata, 2019, Potential Influences of Gut Microbiota on the Formation of Intracranial Aneurysm, Hypertension (Dallas Tex. 1979), 73, 491, 10.1161/HYPERTENSIONAHA.118.11804

Si, 2020, Colorectal cancer occurrence and treatment basedon changes in intestinal flora, Semin. Cancer Biol., S1044-579X(20)30100-0

Sittipo, 2019, Microbial Metabolites Determine Host Health andthe Status of Some Diseases, Int. J. Mol. Sci., 20, 5296, 10.3390/ijms20215296

Skye, 2018, Microbial Transplantation with Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential, Circ. Res., 123, 1164, 10.1161/CIRCRESAHA.118.313142

Thaiss, 2016, Persistent microbiome alterations modulate the rate of post-dieting weight regain, Nature, 540, 544, 10.1038/nature20796

Tischmann, 2019, Effects of a High-Protein/Moderate-CarbohydrateDiet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study, Nutrients, 11, 2269, 10.3390/nu11102269

Toral, 2019, Critical Role of the Interaction Gut Microbiota - Sympathetic Nervous System in the Regulation of Blood Pressure, Front. Physiol., 10, 10.3389/fphys.2019.00231

Tsoi, 2017, Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice, Gastroenterology, 152, 1419, 10.1053/j.gastro.2017.01.009

Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414

Turnbaugh, 2009, The Effect of Diet on the Human Gut Microbiome:A Metagenomic Analysis in Humanized Gnotobiotic Mice, Sci. Trans.Med., 1, 6ra14, 10.1126/scitranslmed.3000322

Vallianou, 2019, Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives, Curr. Obes. Rep., 8, 317, 10.1007/s13679-019-00352-2

Veiga-Fernandes, 2016, Neuro-Immune Interactions at Barrier Surfaces, Cell, 165, 801, 10.1016/j.cell.2016.04.041

Wang, 2011, Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922

Wang, 2018, [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease], Zhonghua Nei Ke Za Zhi, 57, 101, 10.3760/cma.j.issn.0578-1426.2018.02.004

Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res., 29, 787, 10.1038/s41422-019-0216-x

Wong, 2017, Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice, Gastroenterology, 153, 1621, 10.1053/j.gastro.2017.08.022

World Obesity FederationObesity and overweight.2020

Wu, 2020, The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study, Cell Metab., 32, 379, 10.1016/j.cmet.2020.06.011

Wu, 2020, Microbiota-derived metabolite promotes HDAC3activity in the gut, Nature, 586, 108, 10.1038/s41586-020-2604-2

Xu, 2011, Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK, J. Hepatol., 55, 673, 10.1016/j.jhep.2010.12.034

Yan, 2017, Alterations of the Gut Microbiome in Hypertension, Front. Cell Infect. Microbiol., 7, 10.3389/fcimb.2017.00381

Yang, 2015, Gut dysbiosis is linked to hypertension, Hypertension (Dallas Tex. 1979), 65, 1331, 10.1161/HYPERTENSIONAHA.115.05315

Yano, 2015, Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis, Cell, 161, 264, 10.1016/j.cell.2015.02.047

You, 2019, Effect of ethanol on lipid metabolism, J. Hepatol., 70, 237, 10.1016/j.jhep.2018.10.037

Zeng, 2020, Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism, Sci. Adv., 6, 10.1126/sciadv.aax6208

Zeng, 2020, Gut Microbiota and Heart, Vascular Injury, Gut Microbiota and Pathogenesis of Organ Injury., 107, 10.1007/978-981-15-2385-4_8

Zhang, 2018, Time for food: The impact of diet on gut microbiota and human health, Nutrition, 51

Zhang, 2020, Intestinal fatty acid-binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability, J. Cell. Mol. Med., 24, 5205, 10.1111/jcmm.15173

Zheng, 2020, Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism, Cell Metab., 10.2139/ssrn.3528695

Zhou, 2020, Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms, Front. Endocrinol., 11, 10.3389/fendo.2020.00125

Zhou, 2020, Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review, Dis. Markers, 2020, 10.1155/2020/3936247

Zhu, 2016, Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk, Cell, 165, 111, 10.1016/j.cell.2016.02.011

Zhu, 2020, Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide, APMIS Acta Pathol. Microbiol. Immunol. Scand., 128, 353, 10.1111/apm.13038

Zubcevic, 2019, Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension, Circ. Res., 125, 104, 10.1161/circresaha.119.313965